Women’s Health Program to Address Hormonal Conditions

WellTheory, a digital health company specializing in autoimmune diseases, launched a women’s health program on Tuesday to support those with hormonal conditions like endometriosis, PCOS, postpartum, hypothyroidism, and menopause.

Based in Atherton, California, WellTheory provides personalized care for autoimmune conditions such as Addison’s Disease, Celiac Disease, Multiple Sclerosis, and Lupus, collaborating with patients' physicians and specialists. The company offers custom care plans focusing on nutrition, stress management, sleep, and movement, with one-on-one video sessions and unlimited expert messaging.

Nike Has the Perfect Gift for Everyone on Your List

This holiday season, skip the guesswork and shop with confidence at Nike. Find thoughtful, stylish, and functional gifts for everyone on your list in one place.

Discover performance gear that takes athletes to the next level or iconic sneakers that make any outfit pop. Keep them cozy with fleece apparel that brings warmth and comfort to their everyday style.

Holiday shopping doesn’t have to be stressful. With curated collections, seamless online browsing, and inspiration for every budget, Nike makes it effortless.

Celebrate the season with Nike and give the gift of sport to your loved ones.

Shop the Gift Guide

The new program connects hormonal imbalances with autoimmune disease, offering hormone testing, personalized care teams, educational resources, and tailored supplement protocols. Patients also receive ongoing support through video calls, messaging, and symptom tracking.

With 80% of those with autoimmune conditions in the U.S. being women, WellTheory aims to address the often-overlooked link between hormones and immune health, particularly during life transitions like pregnancy and menopause. Co-founder Ellen Rudolph, who personally struggled with hormonal imbalances, believes this program provides much-needed, personalized care that treats the whole person, not just symptoms.

WellTheory will measure the program's success through patient-reported outcomes, clinical improvements, and workplace productivity.